Business Description
Description
Nichiban Co Ltd is a Japan based company engaged in the business of manufacturing and selling products in the field of medical supplies, healthcare, industrial products and industrial products. It offers hemostatic solutions, wound care dressing and surgical tapes, industrial products for manufacturing and distribution and automotive industry, stationery products, TDS pharmaceutical pain relief plaster and foot care products, sports medical battlewin taping tape and first aid bandage.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.1 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 1.06 | |||||
| Interest Coverage | 46.81 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.1 | |||||
| 3-Year EBITDA Growth Rate | -9.5 | |||||
| 3-Year EPS without NRI Growth Rate | -17.2 | |||||
| 3-Year FCF Growth Rate | 6.3 | |||||
| 3-Year Book Growth Rate | 2.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.93 | |||||
| 9-Day RSI | 37.12 | |||||
| 14-Day RSI | 44.41 | |||||
| 6-1 Month Momentum % | 11.18 | |||||
| 12-1 Month Momentum % | 8.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.18 | |||||
| Quick Ratio | 1.68 | |||||
| Cash Ratio | 0.86 | |||||
| Days Inventory | 93.03 | |||||
| Days Sales Outstanding | 74.62 | |||||
| Days Payable | 48.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.65 | |||||
| Dividend Payout Ratio | 0.48 | |||||
| 3-Year Dividend Growth Rate | -7.6 | |||||
| Forward Dividend Yield % | 3.85 | |||||
| 5-Year Yield-on-Cost % | 1.28 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.46 | |||||
| Operating Margin % | 3.93 | |||||
| Net Margin % | 2.94 | |||||
| ROE % | 3.35 | |||||
| ROA % | 2.04 | |||||
| ROIC % | 2.7 | |||||
| ROC (Joel Greenblatt) % | 6.83 | |||||
| ROCE % | 3.94 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.64 | |||||
| PE Ratio without NRI | 29.07 | |||||
| Shiller PE Ratio | 18.88 | |||||
| PS Ratio | 0.84 | |||||
| PB Ratio | 0.96 | |||||
| Price-to-Tangible-Book | 0.99 | |||||
| Price-to-Free-Cash-Flow | 39.56 | |||||
| Price-to-Operating-Cash-Flow | 9.13 | |||||
| EV-to-EBIT | 13.1 | |||||
| EV-to-EBITDA | 13.1 | |||||
| EV-to-Revenue | 0.56 | |||||
| EV-to-FCF | 26.94 | |||||
| Price-to-Projected-FCF | 1.11 | |||||
| Price-to-Median-PS-Value | 1.08 | |||||
| Price-to-Graham-Number | 1.12 | |||||
| Price-to-Net-Current-Asset-Value | 3.66 | |||||
| Earnings Yield (Greenblatt) % | 7.64 | |||||
| Forward Rate of Return (Yacktman) % | -24.05 |
